Abstract
I-FP-CIT and
Visual analysis showed that the striatal uptake of both radiotracers was decreased in the PD group, whereas striatal uptake was intact in the ET group. The SBR between 
| I N TR ODU C TI ON
Parkinson's disease (PD) is the second most common disease among the neurodegenerative disorders (Mirdamadi, 2016) . The loss of dopaminergic neurons in the substantia nigra causes PD, which is characterized by motor impairment symptoms, including bradykinesia, rigidity, resting tremor, and postural instability (Mirdamadi, 2016) .
Rigidity, bradykinesia, and resting tremor is the most important clinical triad. However, in the early stage, PD is difficult to diagnose considering only the clinical symptoms (Eshuis et al., 2009) . Furthermore, the clinical symptoms cannot be distinguished from the parkinsonism of other neurological diseases (Eshuis, Maguire, Leenders, Jonkman, & Jager, 2006) . Several studies evaluated the accuracy of clinical diagnosis of PD (Postuma & Berg, 2017) . The level of diagnostic accuracy of PD determined by neurologists using clinical signs ranged from 65 to 99% (Postuma & Berg, 2017) .
At present, in addition to clinical signs, several functional brain imaging techniques have been developed for the accurate diagnosis of PD. These modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), and functional magnetic resonance imaging, are helpful for measuring local changes in brain blood flow, metabolism, and receptor binding associated with PD (Brooks, 2008) . In addition, several target molecules are used for assessing the function of the striatal dopamine terminal in PD patients (Brooks, 2008) . The most widely used target molecule is the presynaptic dopamine transporter (DAT), which can be detected with different radiotracers using PET and SPECT, (Brooks, 2008) . DAT, which is located at the presynaptic nigrostriatal terminal, mediates dopamine uptake from the synaptic cleft (Saeed et al., 2017) .
DAT has fast kinetics, high selectivity, and compatibility for treatments using levodopa (Saeed et al., 2017) . It was reported that DAT imaging, a presynaptic neuronal functional imaging, is abnormal in the brain of patients with PD (Ramani, Malek, Patterson, Nissen, & Newman, 2017) . This finding improves diagnostic accuracy in PD patients with clinically uncertain parkinsonian symptoms (Ramani et al., 2017) . It was also reported that the downregulation of DAT is an early response to the decrease of endogenous dopamine (Eshuis et al., 2009) . With regard to diagnostic imaging, the decrease of the striatal binding of FP-CIT, a DAT tracer, is associated with the downregulation of DAT in patients with early PD (Eshuis et al., 2009 ). Therefore, FP-CIT can be applied more sensitively for the detection of early striatal dopaminergic deficits (Eshuis et al., 2009 ). Many studies have reported that the striatal binding of FP-CIT in patients with PD is diminished compared to that in normal subjects (Eshuis et al., 2006) . FP-CIT has a high uptake in the brain, fast kinetics, and high specific binding ratio (SBR) (Booij et al., 1997) . Therefore, it is convenient to use FP-CIT clinically.
After approval in Europe, 123 I-FP-CIT has been widely used in SPECT for the differential diagnosis between PD and essential tremor (ET) (Ba & Martin, 2015; Varrone & Halldin, 2014) . 123 I-FP-CIT was commercially introduced as DaTSCAN TM (GE Healthcare, Brussels) (Ba & Martin, 2015) .
Several studies and meta-analyses involving DaTSCAN TM reported that it could differentiate Parkinson's disease from patients with parkinsonism with a relatively high sensitivity and specificity (Ba & Martin, 2015; Brigo, Matinella, Erro, & Tinazzi, 2014) . PET has a higher resolution and sensitivity than SPECT, and 18 F-labeled radiotracer, one of the PET radioligands, can provide images with better quality because of its shorter positron range and high intrinsic resolution (Varrone & Halldin, 2014) . Therefore,
18
F-FP-CIT has been developed and used for the diagnosis of PD as a PET agent.
Several studies to date have compared FP-CIT with other tracers (Eshuis et al., 2006 (Eshuis et al., , 2009 I-FP-CIT SPECT on the same subjects with PD or ET.
| M E TH ODS

| Patients
Patients older than 30 years and clinically diagnosed with PD or ET between May 2014 and May 2017 at our institution were prospectively recruited for this study. The patients with PD were diagnosed using the UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (Hughes, Daniel, Kilford, & Lees, 1992) . The patients with ET were diagnosed using the Essential Tremor criteria of the Movement Disorder Society on Tremor (Deuschl, Bain, & Brin, 1998) . The Hoehn & Yahr stage was applied for the evaluation of clinical severity (Hoehn & Yahr, 1967) . The numbers of patients with PD and ET was 8, respectively. The study design was approved by the Review Board of our institution (IRB No.: KCCH-2014-FPCIT) , and written informed consents were obtained from all patients. All procedures were performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. F-FP-CIT were supplied by the Korea Institute of Radiological and Medical Sciences (Kim et al., 2006; Neumeyer et al., 1994) . I-FP-CIT SPECT/CT scans were performed according to the modified previous guideline (Djang et al., 2012) . Briefly, the thyroid was protected from free I by administering a potassium iodide solution orally one day before, on the day, and one day after tracer injection. The subjects were not allowed to take drugs that interacted with 123 I-FP-CIT.
| Image acquisition
123
I-FP-CIT (185 MBq) was injected intravenously, and brain SPECT was performed 3 h after injection using a dual-head gamma camera equipped with low-energy-high-resolution collimators of a hybrid SPECT/CT scanner (SymbiaT2, Siemens Medical Solutions). The photopeak was centered at 159 keV, and the energy window was opened by 65%. SPECT was acquired in the step-and-shoot mode, matrix 128 3 128, and 3-degree steps for 30 min. After that, CT scans were acquired for attenuation correction. The SPECT images were reconstructed using the 3D ordered subset expectation maximization algorithm (Flash 3D TM ) provided by Siemens using 10 iterations and 10 subsets.
18
F-FP-CIT PET/CT scans were performed using a methodology described previously (Jeong et al., 2013) . Patients were intravenously injected with 18 F-FP-CIT (185 MBq), and PET/CT was performed 3 h after injection using a PET/CT scanner (Biograph 6 TruePoint True V, Siemens Medical Solutions). A CT scan was acquired for attenuation correction and anatomical localization. CT images were reconstructed into 3 mm-thick slices.
Subsequently, PET images from the skull vertex to the skull base were obtained for 3.5 min per bed position, and images were reconstructed using a conventional iterative algorithm and parameters with four iterations and eight subsets. The PET/CT and SPECT/CT images were analyzed using a commercial workstation software (SyngoMI, Siemens Medical Solutions). The striatum was divided into four regions: Two bilateral caudate nuclei and two putamina. The uptake score for each region on PET and SPECT images was assessed independently by two nuclear medicine physicians based on a 4-point scale, as follows: 0 5 Complete uptake in bilateral putamen and caudate nuclei, 1 5 Asymmetric reduced uptake on one side of putamen, 2 5 Reduced uptake on bilateral putamen, 3 5 Bilaterally reduced uptake on both putamen and caudate nuclei. Score 0 was regarded as normal uptake whereas the other scores were regarded as abnormal uptake. This was based on a previously reported semi-quantitative 4-point scale (Benamer et al., 2000) . The scores for normal uptake were classified into two subgroups. In cases in which the scores on the same image calculated by the two examiners were inconsistent, a consensus score was determined after discussion between the two examiners.
| Semiautomatic quantification
For semiautomatic quantification, PET and SPECT images were spatially normalized into standard images using premade 18 F-FP-CIT PET and 123 I-FP-CIT SPECT templates, respectively (Choi et al., 2016; Kim et al., 2012; Lee & Lee, 2005) . This process was performed using the Statistical Parametric Mapping software version 8 (SPM8, Wellcome Department of Imaging Neuroscience, University College of London, UK) in MATLAB (MathWorks, Natick, MA). The mean counts of each area in the striatum, including bilateral putamina and caudate nuclei, were measured by delineating each region using the automated anatomical labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002) . The reference tissue was defined as the cerebellum, which was also delineated with the AAL atlas. After that, the mean counts on 18 F-FP-CIT PET and 123 I-FP-CIT SPECT images were calculated using the MATLAB software. SBR and PCR were obtained for comparisons between PET and SPECT images. SBR was defined using the following formula: (Mean count of each region -mean count of reference tissue)/mean count of the reference tissue. PCR was defined as the ratio of the mean count in the bilateral putamina to the mean count in the bilateral caudate nuclei (Jeong et al., 2013) .
| Statistics
All data are described as means 6 standard deviations (SD). 
| R E SU LTS
| Patient demographics
The PD patients with variable clinical symptoms were recruited in this study. The ET patients were used as the control group. The clinical features of patients are described in Table 1 .
| 3 of 10 3.2 | Rate of interobserver and intermodality agreement
The overall rates of agreement by the two physicians using the 4-point visual scale are shown in Table 2 . The visual score on 
| Comparison of semiautomated quantitative analyses
One patient in the PD group was excluded from this analysis. This patient belonged to the SWEDD group and was not used for the differential diagnosis of PD and ET. Therefore, data from seven PD and eight ET patients were used in the analyses.
| SBR
After dividing the striatum of the 15 subjects into bilateral putamina and caudate nuclei, all 60 SBRs on In the putamina in the PD group, the SBR on I-FP-CIT SPECT in the ET group was 2.22 6 .49 and 1.55 6 .31, respectively (p 5 .01; Figure 5f ). The coefficient of variation (CoV) of the SBR was evaluated. In the case of the putamen of the PD group, the CoVs of 
| PCR
The PCRs on 
| D I SCUSSION
In this study, we directly compared Our results indicated that the visual diagnostic performance for PD between 18 F-FP-CIT PET and 123 I-FP-CIT SPECT scans was not significantly different. However, in the interobserver analysis, the evaluation of striatal uptake showed some discrepancies using the 4-point scale.
The rates of agreement for visual assessment on 123 I-FP-CIT SPECT between the two examiners were lower than those on 18 F-FP-CIT PET.
This result is associated with the different SBRs obtained using these two CT techniques. In the distribution of measured visual scores, the scores on 123 I-FP-CIT SPECT were slightly lower than those on 18 F-FP-CIT PET. These results are also due to differences in SBRs and sensitivity between the two techniques. I-FP-CIT SPECT is mainly based on imaging modalities. However, the molecular structure of the two studied radiotracers is similar. These two tracers differ only in the radiotracers and their labeling sites (Seo et al., 2014) . Therefore, the affinity of these tracers for DAT is identical (Seo et al., 2014) . When compared with SPECT, PET has higher spatial resolution and higher sensitivity to signal, which produces better image quality for analysis (Lee et al., 2015) . The SBR on SPECT may be underestimated because of the method of attenuation correction. A previous study on 123 I-FP-CIT SPECT reported that the binding potential using the CT-attenuation correction method was significantly lower than the potential using the calculated uniform attenuation matrix (Chang's method) (Lapa et al., 2015) . Another study reported that CTattenuation correction had a lower SBR than Chang's method on 123 I-FP-CIT SPECT (Lange et al., 2014) . In this study, CT-attenuation correction was used to calculate the SBR on SPECT. Therefore, the SBR on SPECT may be lower than the SBR measured using other attenuation correction methods. Another important factor is the metabolite of In this study, the patients with PD showed lower FP-CIT uptake in the whole striatum compared to ET patients. It was observed that the reduced uptake in the dorsal posterior putamen was prominent, as observed in previous studies (Ibrahim et al., 2016) . In ET patients, striatal uptake of FP-CIT on PET and SPECT was preserved and was considered normal. This uptake pattern was previously reported in other studies I-FP-CIT SPECT for discriminating PD and ET groups showed that all values of the ET group were higher than those of the PD group. However, these differences were statistically significant only in PCR values. Considering the limited number of subjects, this finding requires further evaluation.
Despite the similar ability to diagnose PD, these methods have distinct advantages. First, This study has some limitations. First, the number of recruited patients was relatively small. In the analysis of the correlation between clinical severity and FP-CIT uptake, statistical significance was not achieved because of the relatively small sample size. Second, the primary objective of this study was to compare imaging parameters, and thus, there is a limit in evaluating the differences in diagnostic performance between I-FP-CIT SPECT. Therefore, further studies with a larger sample size are needed to determine the effect of differences in SBR, PCR, and agreement in visual assessment on diagnostic performance.
